Oasis TEARS ® Preservative-Free Lubricant Eye Drops

Manufacturer: OASIS Medical, Inc. | LABORATOIRE UNITHER COUTANCES | UNITHER MANUFACTURING LLC
Effective date: 2024-12-23
Label type: HUMAN OTC DRUG LABEL
Version: 4
Source: full-release
Hydrated at: 2026-06-01 00:53:21

Label at a glance#

ProductOASIS Tears Preservative-Free Lubricant Eye

Active ingredientGLYCERIN

Label structure10 sections

Indications and uses

for the temporary relief of burning and irritation due to dryness of the eye. for the temporary relief of discomfort due to minor irritations of the eye or to exposure to wind or sun. for use as a protectant against further irritation or to relieve dryness of the eye. for use as a lubricant to prevent further irritation or to relieve dryness of the eye.

Dosage and administration

instill 1 or 2 drops in the affected eye(s) as needed.

Storage and handling

protect from light and freezing store at or below 77°F (25°C) and above 32°F (0°C).

Contacts and useful links#

PhoneLabel contact(800) 631-7180

PhoneLabel contact(909) 305-5400

Websitewww.oasistears.com

www.oasistears.com

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

Drug Facts

Active Ingredients

OTC - ACTIVE INGREDIENT SECTION

Glycerin (0.22%)

Purpose

OTC - PURPOSE SECTION

Lubricant Eye Drops

Uses

INDICATIONS & USAGE SECTION

for the temporary relief of burning and irritation due to dryness of the eye.
for the temporary relief of discomfort due to minor irritations of the eye or to exposure to wind or sun.
for use as a protectant against further irritation or to relieve dryness of the eye.
for use as a lubricant to prevent further irritation or to relieve dryness of the eye.

Warnings

WARNINGS SECTION

For external use only

Do not use

OTC - DO NOT USE SECTION

if solution changes color or becomes cloudy.
if you are sensitive to any ingredient in this product.

When using this product

OTC - WHEN USING SECTION

to avoid contamination do not touch tip of container to any surface.
once opened, discard
do not reuse

Stop use and ask a doctor if

OTC - STOP USE SECTION

you experience eye pain, changes in vision, continued redness or irritation of the eye, or if the conditions worsens or persists for more than 72 hours.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

instill 1 or 2 drops in the affected eye(s) as needed.

Questions, or to report an adverse event call

OTC - QUESTIONS SECTION

(800) 631-7180 or (909) 305-5400 or log onto www.oasistears.com

Other Information

STORAGE AND HANDLING SECTION

protect from light and freezing
store at or below 77°F (25°C) and above 32°F (0°C).

Inactive Ingredients

INACTIVE INGREDIENT SECTION

Sodium chloride, sodium hyaluronate, sodium phosphate dibasic, sodium phosphate monobasic, water.

PRINCIPAL DISPLAY PANEL - 0.3 mL Pouch Carton

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

N 42126-6100-1

Oasis
TEARS^®

PRESERVATIVE - FREE

LUBRICANT EYE DROPS

VISCOADAPTIVE RELIEF
FOR DRY EYES

30
STERILE (0.3 mL/0.01 FL. OZ.)
SINGLE USE CONTAINERS

Principal Display Panel - 0.3 mL Pouch Carton

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	SPL version
2702674	glycerin 0.22 % Ophthalmic Solution	PSN	4
2702676	Oasis TEARS PF 0.22 % Ophthalmic Solution	PSN	4
2702676	glycerin 2.2 MG/ML Ophthalmic Solution [Oasis Tears]	SBD	4
2702674	glycerin 2.2 MG/ML Ophthalmic Solution	SCD	4
2702674	glycerin 0.22 % Ophthalmic Solution	SY	4
2702676	Oasis Tears 2.2 MG/ML Ophthalmic Solution	SY	4
2702676	Oasis Tears PF 0.22 % Ophthalmic Solution	SY	4

DailyMed Pharmacologic Classes#

Class, Version, Type table
Class	Version	Type	Effective
GLYCERIN Pharmacologic Class Indexing	2	Indexing - Pharmacologic Class	20180813

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
42126-6100-1	OASIS TearsPreservative-Free Lubricant Eye	10 in 1 POUCH	SOLUTION/ DROPS	10	4
42126-6100-1	OASIS TearsPreservative-Free Lubricant Eye	3 in 1 CARTON	SOLUTION/ DROPS	3	4
42126-6100-2	OASIS TearsPreservative-Free Lubricant Eye	5 in 1 POUCH	SOLUTION/ DROPS	5	4
42126-6100-2	OASIS TearsPreservative-Free Lubricant Eye	0.3 mL in 1 VIAL, SINGLE-USE	SOLUTION/ DROPS	0.3	4

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
42126-6100	OASIS TEARS PRESERVATIVE-FREE LUBRICANT EYE (GLYCERIN) SOLUTION/ DROPS [OASIS MEDICAL, INC.]	4	Current NDC, Legacy NDC, 4 package rows	20250122_d9d71b1d-82a6-42e7-9ef2-2d041daef936.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	SPL version
Glycerin	ACTIVE INGREDIENT	PDC6A3C0OX	1
Glycerin	ACTIVE MOIETY	PDC6A3C0OX	1
Hyaluronate Sodium	INACTIVE INGREDIENT	YSE9PPT4TH	1
Sodium chloride	INACTIVE INGREDIENT	451W47IQ8X	1
Sodium phosphate, dibasic	INACTIVE INGREDIENT	GR686LBA74	1
Sodium phosphate, monobasic	INACTIVE INGREDIENT	3980JIH2SW	1
Water	INACTIVE INGREDIENT	059QF0KO0R	1

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 7 matching rows.

OASIS Tears Preservative-Free Lubricant Eye
Glycerin
HYALURONATE SODIUM
SODIUM CHLORIDE
SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM
SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM
WATER

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
42126-6100	42126-6100-1, 42126-6100-2

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 6 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
GLYCERIN	PDC6A3C0OX	ACTIB
HYALURONATE SODIUM	YSE9PPT4TH	IACT
SODIUM CHLORIDE	451W47IQ8X	IACT
SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM	3980JIH2SW	IACT
SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM	GR686LBA74	IACT
WATER	059QF0KO0R	IACT

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 1 · 48 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredient	IID ingredient	UNII	Dosage form / route	Potency	Maximum daily exposure	Match
Sodium phosphate, monobasic	SODIUM PHOSPHATE, MONOBASIC	3980JIH2SW	INJECTION / INTRAVENOUS		161 mg	Exact identifier — unii candidate 27 equally ranked IID candidates
Sodium phosphate, monobasic	SODIUM PHOSPHATE, MONOBASIC	3980JIH2SW	SYSTEM / IONTOPHORESIS	14.2 mg		Exact identifier — unii candidate 27 equally ranked IID candidates
Sodium phosphate, monobasic	SODIUM PHOSPHATE, MONOBASIC	3980JIH2SW	SOLUTION / ORAL	25 mg/5ml		Exact identifier — unii candidate 27 equally ranked IID candidates
Hyaluronate Sodium	HYALURONATE SODIUM	YSE9PPT4TH	GEL / TOPICAL		463 mg	Exact identifier — unii candidate 15 equally ranked IID candidates
Sodium phosphate, monobasic	SODIUM PHOSPHATE, MONOBASIC	3980JIH2SW	INJECTION / INTRAMUSCULAR		161 mg	Exact identifier — unii candidate 27 equally ranked IID candidates
Hyaluronate Sodium	HYALURONATE SODIUM	YSE9PPT4TH	INJECTION, SUSPENSION / INTRAVITREAL		23 mg	Exact identifier — unii candidate 15 equally ranked IID candidates
Hyaluronate Sodium	HYALURONATE SODIUM	YSE9PPT4TH	GEL / TOPICAL		463 mg	Exact identifier — unii candidate 15 equally ranked IID candidates
Hyaluronate Sodium	HYALURONATE SODIUM	YSE9PPT4TH	INJECTION, SUSPENSION / INTRAMUSCULAR		23 mg	Exact identifier — unii candidate 15 equally ranked IID candidates
Sodium phosphate, monobasic	SODIUM PHOSPHATE, MONOBASIC	3980JIH2SW	INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS	13.2 mg		Exact identifier — unii candidate 27 equally ranked IID candidates
Hyaluronate Sodium	HYALURONATE SODIUM	YSE9PPT4TH	INJECTION, SUSPENSION / INTRAMUSCULAR		23 mg	Exact identifier — unii candidate 15 equally ranked IID candidates
Sodium phosphate, monobasic	SODIUM PHOSPHATE, MONOBASIC	3980JIH2SW	INJECTION / INTRAVENOUS		161 mg	Exact identifier — unii candidate 27 equally ranked IID candidates
Sodium phosphate, dibasic	SODIUM PHOSPHATE, DIBASIC	GR686LBA74	SUSPENSION / OPHTHALMIC	0.43 %w/w		Exact identifier — unii+route 3 equally ranked IID candidates
Sodium phosphate, dibasic	SODIUM PHOSPHATE, DIBASIC	GR686LBA74	SUSPENSION / OPHTHALMIC	0.43 %w/w		Exact identifier — unii+route 3 equally ranked IID candidates
Hyaluronate Sodium	HYALURONATE SODIUM	YSE9PPT4TH	GEL / TOPICAL		463 mg	Exact identifier — unii candidate 15 equally ranked IID candidates
Hyaluronate Sodium	HYALURONATE SODIUM	YSE9PPT4TH	LOTION / TOPICAL	0.01 %w/w		Exact identifier — unii candidate 15 equally ranked IID candidates
Sodium phosphate, monobasic	SODIUM PHOSPHATE, MONOBASIC	3980JIH2SW	INJECTION / INTRAMUSCULAR		161 mg	Exact identifier — unii candidate 27 equally ranked IID candidates
Sodium phosphate, monobasic	SODIUM PHOSPHATE, MONOBASIC	3980JIH2SW	SOLUTION / ORAL	25 mg/5ml		Exact identifier — unii candidate 27 equally ranked IID candidates
Sodium phosphate, monobasic	SODIUM PHOSPHATE, MONOBASIC	3980JIH2SW	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / SUBCUTANEOUS	0.22 mg		Exact identifier — unii candidate 27 equally ranked IID candidates
Sodium phosphate, monobasic	SODIUM PHOSPHATE, MONOBASIC	3980JIH2SW	INJECTION / INTRAVENOUS		161 mg	Exact identifier — unii candidate 27 equally ranked IID candidates
Sodium phosphate, dibasic	SODIUM PHOSPHATE, DIBASIC	GR686LBA74	SUSPENSION / OPHTHALMIC	0.43 %w/w		Exact identifier — unii+route 3 equally ranked IID candidates
Hyaluronate Sodium	HYALURONATE SODIUM	YSE9PPT4TH	INJECTION, SUSPENSION / INTRAVITREAL		23 mg	Exact identifier — unii candidate 15 equally ranked IID candidates
Sodium phosphate, monobasic	SODIUM PHOSPHATE, MONOBASIC	3980JIH2SW	INJECTION / INTRAMUSCULAR		161 mg	Exact identifier — unii candidate 27 equally ranked IID candidates
Sodium phosphate, monobasic	SODIUM PHOSPHATE, MONOBASIC	3980JIH2SW	TABLET / ORAL		2 mg	Exact identifier — unii candidate 27 equally ranked IID candidates
Sodium phosphate, monobasic	SODIUM PHOSPHATE, MONOBASIC	3980JIH2SW	SYSTEM / IONTOPHORESIS	14.2 mg		Exact identifier — unii candidate 27 equally ranked IID candidates
Sodium phosphate, monobasic	SODIUM PHOSPHATE, MONOBASIC	3980JIH2SW	INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS	13.2 mg		Exact identifier — unii candidate 27 equally ranked IID candidates
Sodium phosphate, monobasic	SODIUM PHOSPHATE, MONOBASIC	3980JIH2SW	INJECTION, SUSPENSION / SUBCUTANEOUS	0.07 %w/v		Exact identifier — unii candidate 27 equally ranked IID candidates
Sodium phosphate, monobasic	SODIUM PHOSPHATE, MONOBASIC	3980JIH2SW	SYSTEM / TOPICAL	14.2 mg		Exact identifier — unii candidate 27 equally ranked IID candidates
Sodium phosphate, monobasic	SODIUM PHOSPHATE, MONOBASIC	3980JIH2SW	INJECTION, SUSPENSION / SUBCUTANEOUS	0.07 %w/v		Exact identifier — unii candidate 27 equally ranked IID candidates
Hyaluronate Sodium	HYALURONATE SODIUM	YSE9PPT4TH	LOTION / TOPICAL	0.01 %w/w		Exact identifier — unii candidate 15 equally ranked IID candidates
Hyaluronate Sodium	HYALURONATE SODIUM	YSE9PPT4TH	INJECTION, SUSPENSION / INTRAMUSCULAR		23 mg	Exact identifier — unii candidate 15 equally ranked IID candidates
Sodium phosphate, monobasic	SODIUM PHOSPHATE, MONOBASIC	3980JIH2SW	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / SUBCUTANEOUS	0.22 mg		Exact identifier — unii candidate 27 equally ranked IID candidates
Hyaluronate Sodium	HYALURONATE SODIUM	YSE9PPT4TH	INJECTION, SUSPENSION / INTRA-ARTICULAR		23 mg	Exact identifier — unii candidate 15 equally ranked IID candidates
Hyaluronate Sodium	HYALURONATE SODIUM	YSE9PPT4TH	LOTION / TOPICAL	0.01 %w/w		Exact identifier — unii candidate 15 equally ranked IID candidates
Sodium phosphate, monobasic	SODIUM PHOSPHATE, MONOBASIC	3980JIH2SW	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / SUBCUTANEOUS	0.22 mg		Exact identifier — unii candidate 27 equally ranked IID candidates
Sodium chloride	SODIUM CHLORIDE	451W47IQ8X	SOLUTION/ DROPS / OPHTHALMIC		55 mg	Exact identifier — unii+route+dosage form 3 equally ranked IID candidates
Hyaluronate Sodium	HYALURONATE SODIUM	YSE9PPT4TH	INJECTION, SUSPENSION / INTRA-ARTICULAR		23 mg	Exact identifier — unii candidate 15 equally ranked IID candidates
Sodium phosphate, monobasic	SODIUM PHOSPHATE, MONOBASIC	3980JIH2SW	INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS	13.2 mg		Exact identifier — unii candidate 27 equally ranked IID candidates
Sodium phosphate, monobasic	SODIUM PHOSPHATE, MONOBASIC	3980JIH2SW	TABLET / ORAL		2 mg	Exact identifier — unii candidate 27 equally ranked IID candidates
Hyaluronate Sodium	HYALURONATE SODIUM	YSE9PPT4TH	INJECTION, SUSPENSION / INTRA-ARTICULAR		23 mg	Exact identifier — unii candidate 15 equally ranked IID candidates
Sodium phosphate, monobasic	SODIUM PHOSPHATE, MONOBASIC	3980JIH2SW	SOLUTION / ORAL	25 mg/5ml		Exact identifier — unii candidate 27 equally ranked IID candidates
Sodium phosphate, monobasic	SODIUM PHOSPHATE, MONOBASIC	3980JIH2SW	TABLET / ORAL		2 mg	Exact identifier — unii candidate 27 equally ranked IID candidates
Sodium phosphate, monobasic	SODIUM PHOSPHATE, MONOBASIC	3980JIH2SW	SYSTEM / TOPICAL	14.2 mg		Exact identifier — unii candidate 27 equally ranked IID candidates
Sodium phosphate, monobasic	SODIUM PHOSPHATE, MONOBASIC	3980JIH2SW	INJECTION, SUSPENSION / SUBCUTANEOUS	0.07 %w/v		Exact identifier — unii candidate 27 equally ranked IID candidates
Sodium phosphate, monobasic	SODIUM PHOSPHATE, MONOBASIC	3980JIH2SW	SYSTEM / TOPICAL	14.2 mg		Exact identifier — unii candidate 27 equally ranked IID candidates
Sodium chloride	SODIUM CHLORIDE	451W47IQ8X	SOLUTION/ DROPS / OPHTHALMIC		55 mg	Exact identifier — unii+route+dosage form 3 equally ranked IID candidates
Sodium chloride	SODIUM CHLORIDE	451W47IQ8X	SOLUTION/ DROPS / OPHTHALMIC		55 mg	Exact identifier — unii+route+dosage form 3 equally ranked IID candidates
Sodium phosphate, monobasic	SODIUM PHOSPHATE, MONOBASIC	3980JIH2SW	SYSTEM / IONTOPHORESIS	14.2 mg		Exact identifier — unii candidate 27 equally ranked IID candidates
Hyaluronate Sodium	HYALURONATE SODIUM	YSE9PPT4TH	INJECTION, SUSPENSION / INTRAVITREAL		23 mg	Exact identifier — unii candidate 15 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
OASIS Tears Preservative-Free Lubricant Eye	GLYCERIN	OASIS Medical, Inc.	d9d71b1d-82a6-42e7-9ef2-2d041daef936	2024-12-23	Warnings	Exact identifier ndc (package): 42126-6100-1 ndc (package): 42126-6100-2 ndc (product): 42126-6100 ndc11 (package): 42126610001 ndc11 (package): 42126610002 spl id: b01eee93-b0f8-4523-8b85-3076dd02a272 spl set id: d9d71b1d-82a6-42e7-9ef2-2d041daef936

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.